Effect of Shock Wave on Vascular Lesions in Diabetic Rats

Juan Long1, Chunjing He1, Hua Ding2

  • 1Guizhou Provincial People's Hospital.

Pain Physician
|September 29, 2019
PubMed
Abstract

Insights

Extracorporeal shock wave therapy improved vascular function in diabetic rats by increasing vascular endothelial growth factors (VEGF) and endothelial nitric oxide synthase (eNOS). This therapy also reduced angiotensin type 1 (AT1) levels, mitigating diabetes-induced vascular damage.

Area of Science:

  • Vascular biology and diabetes research.
  • Experimental therapeutics and regenerative medicine.

Background:

  • Diabetes mellitus is a prevalent condition associated with significant vascular complications.
  • Existing evidence on extracorporeal shock wave therapy (ESWT) for diabetic vascular disease remains limited.
  • Diabetic vascular disease can lead to severe health issues, including renal insufficiency and blindness.

Purpose of the Study:

  • To investigate the therapeutic effects of shock wave therapy on vascular lesions in a diabetic rat model.
  • To evaluate the impact of ESWT on key molecular markers of vascular health in diabetes.

Main Methods:

  • An experimental study involving Sprague Dawley rats divided into control, diabetic, and diabetic+ESWT groups.
  • Diabetic rat models were induced using streptozotocin injection.
  • Femoral artery treatment with ESWT for four weeks, followed by electron microscopy and molecular analysis (VEGF, eNOS, AT1) via Western blot and real-time PCR.

Main Results:

  • ESWT significantly increased vascular endothelial growth factors (VEGF) and endothelial nitric oxide synthase (eNOS) levels in diabetic rats compared to untreated diabetic rats.
  • Angiotensin type 1 (AT1) levels were elevated in diabetic rats, but significantly reduced in the ESWT group.
  • Electron microscopy revealed smoother vascular endothelium and tighter basement membranes in rats treated with ESWT.

Conclusions:

  • Shock wave therapy demonstrates potential in promoting neovascularization and improving vasomotor function in diabetic rats.
  • ESWT may mitigate vascular damage caused by diabetes through the upregulation of VEGF and eNOS, and downregulation of AT1.
  • These findings suggest ESWT as a promising therapeutic approach for diabetic vascular complications.